Mankind Pharma Share Price
Large Cap | Pharmaceuticals and health care | NSE: MANKIND | BSE: 543904
₹2,451.20 
23.50 (0.97 %)
Last Updated: 04 Apr 2025 03:59 PM
BULLISH
Overview
Open (₹) 2,429.00
High (₹) 2,463.45
Low (₹) 2,405.00
Prev. Close (₹) 2,427.70
Volume 3,93,371
VWAP (₹) 2,286.71
ROCE (%) 24.56
Industry P/E 44.73
TTM P/E 49.54
P/B Ratio 10.25
Market Cap (₹) Cr.1,01,131.25
Dividend Yield (%)--
EPS (₹) 47.68
ROE19.95%
Sales Growth (%) 18.12
Profit Growth (%)48.51
Day Range
2,463.452,463.45
52 Week Range
1,910.103,050.00
Historical Returns
Returns (6M)
-4.31 %
Returns (1Y)
4.54 %
Returns (3Y)
72.34 %
Returns (5Y)
72.34 %
Returns (6M)
-4.31 %
Returns (1Y)
4.54 %
Returns (3Y)
72.34 %
Returns (5Y)
72.34 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (49.00%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 49.00% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BULLISHRSI 60.27
MFI 20.44
ATR 87.74
Commodity Channel Index -107.33
ROC125 -5.58
ROC21 -7.84
Williams %R -79.79
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2,372.10 | 2,453.60 | 2,528.15 | 2,297.55 | 2,216.05 | 2,141.50 | 2,060.00 |
| Week Ago | 2,353.15 | 2,378.55 | 2,399.10 | 2,332.60 | 2,307.20 | 2,286.65 | 2,261.25 |
| Month Ago | 2,511.11 | 2,565.53 | 2,628.06 | 2,448.58 | 2,394.16 | 2,331.63 | 2,277.21 |
EMA & SMA
2451.20
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
4
5 Day 2316.38
9 Day 2335.61
10 Day 2349.20
12 Day 2378.56
14 Day 2393.04
20 Day 2424.42
26 Day 2435.84
50 Day 2607.09
100 Day 2610.42
200 Day 2426.30
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| COPTHALL MAURITIUS INVESTMENT LIMITED | block | Sell | 05 Feb, 2025 | ₹2,555.10 | 45,000 | NSE |
| ORBIMED GENESIS MASTER FUND L.P. | block | Buy | 05 Feb, 2025 | ₹2,555.10 | 45,000 | NSE |
| HEMA CIPEF (I) LIMITED | block | Sell | 10 Jul, 2024 | ₹2,082.00 | 18,50,850 | NSE |
| VERITION MULTI-STRATEGY MASTER FUND LTD. | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 48,032 | NSE |
| SOCIETE GENERALE | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 1,20,078 | NSE |
| PICTET - INDIAN EQUITIES | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 3,21,221 | NSE |
| PGGM WORLD EQUITY II B.V. | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 10,585 | NSE |
| NUVAMA ENHANCED DYNAMIC GROWTH EQUITY (EDGE) FUND | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 48,031 | NSE |
| NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 2,88,631 | NSE |
| NATIONAL PENSION SERVICE | block | Buy | 10 Jul, 2024 | ₹2,082.00 | 37,447 | NSE |
| BEIGE LIMITED | bulk | Sell | 26 Mar, 2024 | ₹2,124.71 | 58,17,874 | NSE |
| HEMA CIPEF (I) LIMITED | bulk | Sell | 12 Dec, 2023 | ₹1,832.80 | 56,26,167 | NSE |
| CAIRNHILL CIPEF LIMITED | bulk | Sell | 12 Dec, 2023 | ₹1,832.30 | 69,62,233 | NSE |
| BEIGE LIMITED | bulk | Sell | 12 Dec, 2023 | ₹1,832.30 | 35,00,000 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 09 Feb, 2024 | Puja Juneja | Disposal | ₹2,107.35 | 22,71,336 | NSE |
| 09 Feb, 2024 | Arjun Juneja | Disposal | ₹2,107.35 | 24,01,128 | NSE |
| 09 Feb, 2024 | Sheetal Arora | Disposal | ₹2,107.35 | 18,17,070 | NSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 03 Apr, 2025 | NSE India | Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 03 Apr, 2025 | BSE India | Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 |
| 30 Mar, 2025 | NSE India | Mankind Pharma Limited has informed the Exchange regarding Alteration of capital |
| 29 Mar, 2025 | NSE India | MANKIND PHARMA LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |
| 29 Mar, 2025 | NSE India | Mankind Pharma Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. |
| 29 Mar, 2025 | BSE India | Increase in Authorized Share Capital of the Company pursuant to effect of the Scheme of arrangement of amalgamation amongst Shree Jee Laboratory Private Limited, JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited |
| 29 Mar, 2025 | BSE India | Effective date of the Scheme of Arrangement for Amalgamation amongst Shree Jee Laboratory Private Limited, JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited |
| 29 Mar, 2025 | NSE India | Effective date of the Scheme of Arrangement for Amalgamation amongst Shree Jee Laboratory Private Limited , JPR Labs Private Limited and Jaspack Industries Private Limited with Mankind Pharma Limited |
| 28 Mar, 2025 | NSE India | MANKIND PHARMA LIMITED has informed the Exchange regarding Amalgamation/ Merger |
| 28 Mar, 2025 | BSE India | Amalgamation of BSV Pharma Private Limited, Step Down Subsidiary with Bharat Serums and Vaccines Limited, Material Subsidiary of the Company |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 14 Jan, 2025 | 23 Jan, 2025 |
| Quarterly Results | -- | 28 Oct, 2024 | 05 Nov, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 31 Jul, 2024 |
| Audited Results & Others | To evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. | 26 May, 2024 | 15 May, 2024 |
| Quarterly Results | -- | 17 Jan, 2024 | 31 Jan, 2024 |
| Quarterly Results | -- | 12 Oct, 2023 | 31 Oct, 2023 |
| Quarterly Results | -- | 20 Jul, 2023 | 02 Aug, 2023 |
| Audited Results | -- | 24 May, 2023 | 30 May, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | |||
|---|---|---|---|---|---|
| Promoter Group | 72.71% | 76.5% | 0% | 0% | 0% |
| Foreign Institutions + | 13.35% | 6.74% | 0% | 0% | 0% |
| Domestic Institutions + | 11.01% | 9.78% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 2.93% | 6.98% | 0% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Mankind Pharma
Mankind Pharma is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1991PLC044843 and registration number is 044843. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 9264.81 Cr. and Equity Capital is Rs. 40.06 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1991
Managing Director
-- --
NSE Symbol
MANKIND
Mankind Pharma Management
| Name | Designation |
|---|---|
| Mr. Ramesh Juneja | Chairman & Wholetime Director |
| Mr. Rajeev Juneja | Vice Chairman & Mng.Director |
| Ms. Sheetal Arora | WholeTime Director & CEO |
| Mr. Satish Kumar Sharma | Whole Time Director |
| Mr. Vivek Kalra | Independent Director |
| Mr. Tilokchand Punamchand Ostwal | Independent Director |
| Mr. Surendra Lunia | Independent Director |
| Mr. Bharat Anand | Independent Director |
| Ms. Vijaya Sampath | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Mankind Pharma
What is the share price of Mankind Pharma?
The share price of Mankind Pharma on 04 Apr, 2025 is ₹ 2,451.20.
What is 52W high and 52W low share price of Mankind Pharma?
The highest and lowest 52W share prices of Mankind Pharma are ₹ 3050.000 and ₹ 1910.100
What is the market cap of Mankind Pharma?
The market capitalization of Mankind Pharma as of 04 Apr, 2025 is ₹ 1,01,131.25 Crores
What is the P/E ratio of Mankind Pharma?
The current P/E ratio of Mankind Pharma as of 04 Apr, 2025 is 44.73
What is the PB ratio of Mankind Pharma?
The PB ratio of Mankind Pharma as of 04 Apr, 2025 is 10.25
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)